Towards the use of cannabinoids as antitumour agents

被引：0
作者：
Guillermo Velasco
Cristina Sánchez
Manuel Guzmán
机构：
[1] Guillermo Velasco,Cristina Sánchez and Manuel Guzmán are at the Department of Biochemistry and Molecular Biology I
[2] School of Biology,undefined
[3] Complutense University,undefined
[4] and the Instituto Universitario de Investigación Neuroquímica (IUIN),undefined
[5] Madrid 28040,undefined
[6] Spain.,undefined
[7] Guillermo Velasco and Manuel Guzmán are also at the Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED),undefined
[8] Madrid 28040,undefined
[9] Spain.,undefined
[10] Guillermo Velasco is also at the Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC),undefined
[11] Madrid 28040,undefined
[12] Spain.,undefined
[13] Manuel Guzmán is also at the Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS),undefined
[14] Madrid 28040,undefined
[15] Spain.,undefined
来源：
Nature Reviews Cancer | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cannabinoids have well-established roles in palliating cancer-associated symptoms, but numerous recent studies also support their antitumorigenic activity. This Opinion article focuses on preclinical studies of the antitumour effects of cannabinoids, including the associated cellular signalling pathways and resistance mechanisms.
引用
收藏
页码：436 / 444
页数：8
相关论文
共 216 条
[1]  
Gaoni Y(1964)Isolation, structure and partial synthesis of an active constituent of hashish J. Am. Chem. Soc. 86 1646-1647
[2]  
Mechoulam R(2008)The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ Br. J. Pharmacol. 153 199-215
[3]  
Pertwee RG(1992)-tetrahydrocannabinol, cannabidiol and Δ Science 258 1946-1949
[4]  
Devane WA(1995)-tetrahydrocannabivarin Biochem. Pharmacol. 50 83-90
[5]  
Mechoulam R(1995)Isolation and structure of a brain constituent that binds to the cannabinoid receptor Biochem. Biophys. Res. Commun. 215 89-97
[6]  
Sugiura T(2010)Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Pharmacol. Rev. 62 588-631
[7]  
Pertwee RG(1990)2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Nature 346 561-564
[8]  
Matsuda LA(1993)International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2 Nature 365 61-65
[9]  
Lolait SJ(2007)Structure of a cannabinoid receptor and functional expression of the cloned cDNA Trends Pharmacol. Sci. 28 39-45
[10]  
Brownstein MJ(2010)Molecular characterization of a peripheral receptor for cannabinoids Br. J. Pharmacol. 160 467-479
12345678910